Gastrointestinal bleeding due to jejunal diverticulosis is an uncommon emergency condition that has been encountered recently in one patient. The case of this patient treated with an emergency laparotomy and a segmentary small bowel resection is here presented. The clinical significance, proper diagnostic evaluation, and treatment of the hemorrhagic complication of jejunal diverticular disease are reviewed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[gastrointestinal hemorrhage
4
hemorrhage diverticula
4
diverticula jejunum--presentation
4
jejunum--presentation case
4
case report
4
report review
4
review literature]
4
literature] gastrointestinal
4
gastrointestinal bleeding
4
bleeding jejunal
4

Similar Publications

Does Frequent Use of Advanced Energy Devices Improve Hysterectomy Outcomes?

Medicina (Kaunas)

December 2024

Department of Obstetrics and Gynecology, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 02841, Republic of Korea.

: The objective of this study was to assess the efficient use of advanced energy devices by examining the impact of their usage frequency on surgical outcomes of total laparoscopic hysterectomies. : A retrospective study was conducted between 2020 and 2023 by a single surgeon. The patients' medical records and surgical videos were reviewed.

View Article and Find Full Text PDF

Efficacy and safety of multi-target tyrosine kinase inhibitor AL2846 combined with gemcitabine in pancreatic cancer.

Invest New Drugs

January 2025

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.

Pancreatic cancer patients urgently need new treatments, and we explored the efficacy and safety of combination therapy with AL2846 and gemcitabine in pancreatic cancer patients. This was a single-arm, single-center, open-label phase I/IIa study (NCT06278493). The dose-escalation phase was designed to evaluate the maximum tolerated dose (MTD) of AL2846 combined with gemcitabine.

View Article and Find Full Text PDF

Increased gastrointestinal bleeding-related mortality during the COVID-19 pandemic.

Therap Adv Gastroenterol

January 2025

F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, West Hollywood 90048, CA, USAKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Article Synopsis
  • The study analyzes national data on gastrointestinal bleeding (GIB) mortality in the U.S. from 2010 to May 2023, highlighting trends and identifying vulnerable populations.
  • Despite a consistent decrease in GIB deaths from 2010 to 2019, there was a surge in excess mortality during the COVID-19 pandemic, especially among young males aged 19-44.
  • By 2023, GIB-related mortality rates returned to expected levels, indicating a resolution of pandemic-related excess deaths.
View Article and Find Full Text PDF

Hereditary hemorrhagic telangiectasia (HHT) is a rare genetic disorder characterized by refractory recurrent epistaxis and gastrointestinal bleeding. Recent studies have reported the hemostatic effects of tyrosine kinase inhibitors on HHT-related bleeding. A 67-year-old man with HHT underwent laparoscopic radical nephrectomy for right renal cell carcinoma discovered during an investigation of anemia.

View Article and Find Full Text PDF

Background: In living donor liver transplantation (LDLT), maintaining hepatic arterial flow is critical for graft survival. Alternative methods are required when the recipient's hepatic artery is unsuitable due to extensive dissection or inadequate flow. This study evaluates the efficacy and safety of splenic artery transposition (SAT) for hepatic arterial reconstruction in LDLT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!